Cite
MLA Citation
Raynier Devillier et al.. “Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast‐phase myeloproliferative neoplasms.” British journal of haematology, vol. 172, 2016, pp. 628–630. http://access.bl.uk/ark:/81055/vdc_100028782150.0x000018